Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort.

Nickels S, Vrieling A, Seibold P, Heinz J, Obi N, Flesch-Janys D, Chang-Claude J.

PLoS One. 2013 Sep 25;8(9):e75088. doi: 10.1371/journal.pone.0075088. eCollection 2013.

2.

Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.

Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL.

J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8. doi: 10.1093/jnci/djr291. Epub 2011 Aug 2.

3.

Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins.

Chae YK, Valsecchi ME, Kim J, Bianchi AL, Khemasuwan D, Desai A, Tester W.

Cancer Invest. 2011 Nov;29(9):585-93. doi: 10.3109/07357907.2011.616252. Epub 2011 Sep 21.

PMID:
21936625
4.

Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort - Differential effects by tumour subtype, NAT2 status, BMI and alcohol intake.

Seibold P, Vrieling A, Heinz J, Obi N, Sinn HP, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol. 2014 Aug;38(4):419-26. doi: 10.1016/j.canep.2014.05.006. Epub 2014 Jun 17.

PMID:
24950597
5.

Statin use and breast cancer: prospective results from the Women's Health Initiative.

Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT; Women's Health Initiative Research Group.

J Natl Cancer Inst. 2006 May 17;98(10):700-7.

PMID:
16705124
6.

Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.

van de Woestijne AP, van der Graaf Y, Liem AH, Cramer MJ, Westerink J, Visseren FL; SMART Study Group.

J Am Coll Cardiol. 2013 Nov 12;62(20):1834-41. doi: 10.1016/j.jacc.2013.04.101. Epub 2013 Aug 21.

7.

Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.

Christiansen P, Bjerre K, Ejlertsen B, Jensen MB, Rasmussen BB, Lænkholm AV, Kroman N, Ewertz M, Offersen B, Toftdahl DB, Møller S, Mouridsen HT; Danish Breast Cancer Cooperative Group.

J Natl Cancer Inst. 2011 Sep 21;103(18):1363-72. doi: 10.1093/jnci/djr299. Epub 2011 Aug 31.

PMID:
21881042
8.

Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort.

Obi N, Heinz J, Seibold P, Vrieling A, Rudolph A, Chang-Claude J, Berger J, Flesch-Janys D.

Int J Cancer. 2016 May 1;138(9):2098-108. doi: 10.1002/ijc.29951. Epub 2015 Dec 30.

9.

Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer: results from the prospective E3N cohort.

Fagherazzi G, Fabre A, Boutron-Ruault MC, Clavel-Chapelon F.

Eur J Cancer Prev. 2010 Mar;19(2):120-5. doi: 10.1097/CEJ.0b013e3283354918.

PMID:
20042864
10.

Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.

Chao C, Jacobsen SJ, Xu L, Wallner LP, Porter KR, Williams SG.

BJU Int. 2013 May;111(6):954-62. doi: 10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.

11.

Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment.

Hoffmeister M, Jansen L, Rudolph A, Toth C, Kloor M, Roth W, Bläker H, Chang-Claude J, Brenner H.

J Natl Cancer Inst. 2015 Mar 13;107(6):djv045. doi: 10.1093/jnci/djv045. Print 2015 Jun.

PMID:
25770147
12.

Mammographic screening reduces risk of breast carcinoma recurrence.

Immonen-Räihä P, Kauhava L, Parvinen I, Holli K, Kronqvist P, Pylkkänen L, Helenius H, Kaljonen A, Räsänen O, Klemi PJ.

Cancer. 2005 Feb 1;103(3):474-82.

13.

Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.

Corrao G, Conti V, Merlino L, Catapano AL, Mancia G.

Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.

PMID:
20206788
14.

Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.

Kwan ML, Chen WY, Kroenke CH, Weltzien EK, Beasley JM, Nechuta SJ, Poole EM, Lu W, Holmes MD, Quesenberry CP Jr, Pierce JP, Shu XO, Caan BJ.

Breast Cancer Res Treat. 2012 Apr;132(2):729-39. doi: 10.1007/s10549-011-1914-3. Epub 2011 Dec 21.

15.

Association of pre-diagnosis physical activity with recurrence and mortality among women with breast cancer.

Schmidt ME, Chang-Claude J, Vrieling A, Seibold P, Heinz J, Obi N, Flesch-Janys D, Steindorf K.

Int J Cancer. 2013 Sep 15;133(6):1431-40. doi: 10.1002/ijc.28130. Epub 2013 Mar 18.

16.

Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study.

Vrieling A, Buck K, Heinz J, Obi N, Benner A, Flesch-Janys D, Chang-Claude J.

Breast Cancer Res Treat. 2012 Nov;136(1):195-207. doi: 10.1007/s10549-012-2230-2. Epub 2012 Sep 11.

PMID:
22961011
17.

Statin use and breast cancer survival: a nationwide cohort study in Scotland.

Mc Menamin ÚC, Murray LJ, Hughes CM, Cardwell CR.

BMC Cancer. 2016 Aug 4;16:600. doi: 10.1186/s12885-016-2651-0.

18.

Statin therapy is associated with improved survival after endovascular and open aneurysm repair.

de Bruin JL, Baas AF, Heymans MW, Buimer MG, Prinssen M, Grobbee DE, Blankensteijn JD; DREAM Study Group.

J Vasc Surg. 2014 Jan;59(1):39-44.e1. doi: 10.1016/j.jvs.2013.07.026. Epub 2013 Oct 18.

19.

Statin use and breast cancer survival: a nationwide cohort study from Finland.

Murtola TJ, Visvanathan K, Artama M, Vainio H, Pukkala E.

PLoS One. 2014 Oct 20;9(10):e110231. doi: 10.1371/journal.pone.0110231. eCollection 2014.

20.

Active smoking and breast cancer risk: original cohort data and meta-analysis.

Gaudet MM, Gapstur SM, Sun J, Diver WR, Hannan LM, Thun MJ.

J Natl Cancer Inst. 2013 Apr 17;105(8):515-25. doi: 10.1093/jnci/djt023. Epub 2013 Feb 28.

PMID:
23449445

Supplemental Content

Support Center